Relation of serum valproate concentration to response in mania

American Journal of Psychiatry

Volumn 153, Issue 6, 1996, Pages 765-770

  Bowden, Charles L ^a   Janicak, Philip G ^b   Orsulak, Paul ^b   Swann, Alan C ^b   Davis, John M ^b   Calabrese, Joseph R ^b   Goodnick, Paul ^b   Small, Joyce G ^b   Rush, A John ^b   Kimmel, Susan E ^b   Risch, S Craig ^b   Morris, David D ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAL HYDRATE; LITHIUM; LORAZEPAM; PLACEBO; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; VERTIGO; VOMITING;

EID: 9344244138     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.6.765     Document Type: Article

References (17)

1. Pope HG, McElroy SL, Keck PE, Hudson JI: Valproate in the treatment of mania: a placebo-controlled study. Arch Gen Psychiatry 1991; 48:62-68
2. Gomez Bellver MJ, Garcia Sanchez MJ, Alonso Gonzalez AC, Santos Buelga D, Dominguez-Gil A: Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications. J Clin Pharm Ther 1993; 18:191-197
3. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty H, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza-Trevino ES, Risch SC, Goodnick PJ, Morris DD: Efficacy of divalproex vs lithium and placebo in the treatment of mania: the Depakote Mania Study Group. JAMA 1994; 271:918-924; correction, 271:1830
4. Henriksen O, Johannessen SI: Clinical and pharmacokinetic observations on sodium valproate: a 5-year follow-up study on 100 children with epilepsy. Acta Neurol Scand 1982; 65:504-523
5. Gram L, Flachs H, Wurtz-Jorgensen A, Parnas J, Andersen B: Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia 1979; 20:303-312
6. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
7. Secunda SK, Kattz MM, Swann A, Koslow SH, Maas JW, Chuang S, Croughan J: Mania, diagnosis, state measurement and prediction of treatment response. J Affect Disord 1985; 8:113-121
8. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
9. Altman EG, Peterson JL, Hedeker DR, Janicak PG, Davis JM: Videotaped reliability in a multicenter collaborative investigation of divalproex sodium for the treatment of mania. Human Psychopharmacology 1994; 9:197-202
10. Murphy DL, Pickar D, Alterman IS: Methods for the quantitative assessment of depressive and manic behavior, in Quantitative Techniques for the Evaluation of the Behavior of Psychiatric Patients. Edited by Burdock EI, Sudilovsky A, Gershon S. New York, Marcel Dekker, 1980, pp 355-392
11. Chadwick DW, Cumming WJK, Livingstone I: Acute intoxication with sodium valproate. Ann Neurol 1979; 6:552-553
12. Emrich HM, von Zerssen D, Kissling W, Möller H-J: Therapeutic effect of valproate in mania (letter). Am J Psychiatry 1981; 138:256
13. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ: Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993; 13:280-283
14. Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E Jr: The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 1987; 17:297-309
15. Greenblatt DJ, Harmatz JS, Shader RI: Plasma alprazolam concentrations: relations to efficacy and side effects in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:715-722
16. Dupuis RE, Lichtman SN, Pollack GM: Acute valproic acid overdose: clinical course and pharmacokinetic disposition of valproic acid and metabolites. Drug Saf 1990; 5:65-71
17. Janicak PG: The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilizers and antipsychotics. J Clin Psychiatry 1993; 95:35-41